TargetMol

Glycerophosphorylethanolamine (sodium salt)

Product Code:
 
TAR-T37531
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T37531-1mg1mg£317.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Glycerophosphorylethanolamine is an active phosphodiester metabolite of phosphatidylethanolamine.1,2It promotes aggregation of amyloid-β (1-40) (Aβ40)in vitro, and levels of glycerophosphorylethanolamine are elevated in postmortem brains isolated from patients with Alzheimer?s disease.
CAS:
883288-78-6
Formula:
C5H13NO6P?Na
Molecular Weight:
237.1
Purity:
0.98
SMILES:
O=P(OCCN)(OCC(CO)O)[O-].[Na+]

References

Blusztajn, J.K., Lopez Gonzalez-Coviella, I., Logue, M., et al.Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer?s disease but not of Down?s syndrome patientsBrain Res.536(1-2)240-244(1990) Klunk, W.E., Xu, C.J., McClure, R.J., et al.Aggregation of ?-amyloid peptide is promoted by membrane phospholipid metabolites elevated in Alzheimer?s disease brainJ. Neurochem.69(1)266-272(1997)